FDA links multiple deaths and injuries to faulty Abbott glucose monitors
TL;DR Summary
The FDA warns that some Abbott FreeStyle Libre 3 and 3 Plus glucose sensors may provide incorrect low readings due to a manufacturing issue, linked to hundreds of adverse events and seven deaths outside the U.S. Patients are advised to stop using affected devices and seek replacements, as the issue has been identified and resolved.
- 7 deaths, hundreds of injuries may be linked to diabetes glucose monitor errors, FDA says CBS News
- 7 deaths, more than 700 serious injuries linked with diabetes glucose monitor errors CNN
- Seven deaths possibly linked to malfunctioning glucose monitors USA Today
- Abbott initiates device correction for millions of glucose sensors Healio
- Abbott initiates medical device correction for certain FreeStyle Libre® 3 and FreeStyle Libre 3 Plus sensors in the U.S. Abbott MediaRoom
Reading Insights
Total Reads
0
Unique Readers
3
Time Saved
2 min
vs 3 min read
Condensed
88%
468 → 55 words
Want the full story? Read the original article
Read on CBS News